Full View

Polycythemia vera and essential thrombocythemia: 2019 update on diagnosis, risk‐stratification and management

A Tefferi, T Barbui - American journal of hematology, 2019 - Wiley Online Library
Abstract Disease Overview: Polycythemia vera (PV) and essential thrombocythemia (ET) are
myeloproliferative neoplasms respectively characterized by erythrocytosis and …
被引用次数：286 相关文章

Polycythemia vera and essential thrombocythemia: 2019 update on diagnosis, risk-stratification and management.

A Tefferi, T Barbui - American Journal of Hematology, 2018 - europepmc.org
Disease Overview: Polycythemia vera (PV) and essential thrombocythemia (ET) are
myeloproliferative neoplasms respectively characterized by erythrocytosis and …

Polycythemia vera and essential thrombocythemia: 2019 update on diagnosis, risk-stratification and management

A Tefferi, T Barbui - American journal of hematology, 2019 - mayoclinic.elsevierpure.com
Abstract Disease Overview: Polycythemia vera (PV) and essential thrombocythemia (ET) are
myeloproliferative neoplasms respectively characterized by erythrocytosis and …

Polycythemia vera and essential thrombocythemia: 2019 update on diagnosis, risk-stratification and management

A Tefferi, T Barbui - American journal of hematology, 2019 - pubmed.ncbi.nlm.nih.gov
Disease Overview: Polycythemia vera (PV) and essential thrombocythemia (ET) are
myeloproliferative neoplasms respectively characterized by erythrocytosis and …

Polycythemia vera and essential thrombocythemia: 2019 update on diagnosis, risk‐stratification and management

A Tefferi, T Barbui - American Journal of Hematology, 2018 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p>< jats: bold> Disease Overview:</jats: bold>
Polycythemia vera (PV) and essential thrombocythemia (ET) are myeloproliferative …